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Thus, there is a clear need of human cell-based  neurotoxicity 
models with which the toxicological effects can be monitored 
online. With non-invasive microelectrode array (MEA), the func-
tional activity of neuronal cell networks can be measured in vitro 
for long periods of time and can be used as an additional real-
time analysis method (Pine, 1980; Ben-Ari, 2001; Wagenaar et al., 
2006; Illes et al., 2007; Heikkilä et al., 2009). As MEA technologies 
offer indeed a proper way to measure the electrical activity of the 
networks and further allow the detection of network responses to 
extrinsic factors these technologies are seen as a promising way to 
rapid and sensitive screening of neurotoxicity testing as discussed 
in recent review by Johnstone et al. (2010).
Human pluripotent, e.g., embryonic stem cells are an excellent 
source to produce the main cells types of the human brain: neurons, 
astrocytes, and oligodendrocytes (Reubinoff et al., 2001; Zhang 
et al., 2001; Erceg et al., 2008; Lappalainen et al., 2010; Sundberg 
et al., 2010). These cells follow the in vivo neural development 
closely and the produced neuronal cells have electrical properties 
of their brain counter parts (Carpenter et al., 2001; Itsykson et al., 
2005; Johnson et al., 2007; Erceg et al., 2008). Importantly, these 
cells can form spontaneously active functional neuronal networks 
(Heikkilä et al., 2009) the activity development of which resembles 
that of rodent primary and embryonic stem cell-derived neuronal 
cultures (Wagenaar et al., 2006; Illes et al., 2007). Methyl mercury is 
IntroductIon
Neurotoxicity of various chemicals is currently tested solely with 
in vivo methods due to the lack of proper, validated in vitro cell models. 
Cells such as primary cultures of rat cerebellar granule cells have been 
used as a possible in vitro model (Harry et al., 1998; van Vliet et al., 
2007; Bal-Price et al., 2009; Hogberg et al., 2009) for both develop-
mental and adult neurotoxicity testing. Recently also human-derived 
cells, e.g., neural progenitor cells and umbilical cord blood-derived 
neural stem cells have been tested for neurotoxicity studies (Zeng 
et al., 2006; Buzanska et al., 2009a,b; Moors et al., 2009; Bal-Price et al., 
2010). In addition to the need of developing human cell-based in vitro 
models that would enable better interpretation of neurotoxicological 
responses in humans and help to replace and reduce animal tests, 
more relevant in vitro toxicological models are needed. Currently used 
in vitro neuronal models are mostly based on molecular biological 
end-point analyses such as gene expression, cell proliferation and 
differentiation, and neurite outgrowth. It has, however, become clear 
that in addition to traditional cell viability testing, the testing pattern 
should include various general cell function tests and especially con-
centrate on neuron-specific aspects such as the neuronal network’s 
electrical functionality and its alterations due to toxic compounds 
in subcytotoxic levels (van Vliet et al., 2007; Bal-Price et al., 2010). 
Validation of all these tests is of high importance for development of 
routinely usable in vitro neurotoxicology testing platforms.
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At present, most of the neurotoxicological analyses are based on in vitro and in vivo models 
utilizing animal cells or animal models. In addition, the used in vitro models are mostly based 
on molecular biological end-point analyses. Thus, for neurotoxicological screening, human 
cell-based analysis platforms in which the functional neuronal networks responses for various 
neurotoxicants can be also detected real-time are highly needed. Microelectrode array (MEA) 
is a method which enables the measurement of functional activity of neuronal cell networks 
in vitro for long periods of time. Here, we utilize MEA to study the neurotoxicity of methyl 
mercury chloride (MeHgCl, concentrations 0.5–500 nM) to human embryonic stem cell (hESC)-
derived neuronal cell networks exhibiting spontaneous electrical activity. The neuronal cell 
cultures were matured on MEAs into networks expressing spontaneous spike train-like activity 
before exposing the cells to MeHgCl for 72 h. MEA measurements were performed acutely 
and 24, 48, and 72 h after the onset of the exposure. Finally, exposed cells were analyzed with 
traditional molecular biological methods for cell proliferation, cell survival, and gene and protein 
expression. Our results show that 500 nM MeHgCl decreases the electrical signaling and alters 
the pharmacologic response of hESC-derived neuronal networks in delayed manner whereas 
effects can not be detected with qRT-PCR, immunostainings, or proliferation measurements. 
Thus, we conclude that human cell-based MEA platform is a sensitive online method for 
neurotoxicological screening.
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diameter 30 and 200 μm inter-electrode distances. In addition, 
also 6-well MEA plates were used, which consists of 6 separated 9 
electrode areas (diameter 30 mm, inter-electrode distance 200 μm). 
In both MEA types, electrode areas were separated with in-house 
designed Poly(dimethyl siloxane) (PDMS) structures (designed and 
manufactured by J. Kreutzer and P. Kallio, Tampere University of 
Technology, Department of Automation Science and Engineering, 
Finland). Cell plating on MEA’s was performed as previously 
described (Heikkilä et al., 2009). First, MEA plates were coated with 
two step coating procedure; overnight incubation with PEI (0.05% 
w/v, incubation +4°C) followed by washing with sterile water, and 
overnight incubation with mouse laminin (20 μg/ml, incubation 
+4°C). Thereafter, neurospheres were cut into small aggregates (∅ 
∼200 μm) and plated onto coated MEA plates. Neuronal differentia-
tion medium supplemented with 4 ng/ml bFGF and 5 ng/ml BDNF 
was applied to cells during MEA culture. The cells and networks 
were grown for 3 weeks before MeHgCl exposure.
MeHgcl exposure
MeHgCl was dissolved into sterile dPBS in stock concentration 
1 mM and thereafter diluted into neuronal differentiation medium 
(containing bFGF and BDNF) freshly just before use. Next, the 
medium containing either 0, 0.5, 50, or 500 nM MeHgCl was 
changed to neuronal networks growing on MEA’s (n = 4/each 
concentration) or in standard 48- and 96-well plates. The cells 
were cultured in MeHgCl containing medium for 72 h where after 
it was washed away.
electropHysIologIcal MeasureMents
Measurements were performed with MEA1060-Inv-BC-amplifier 
with integrated TPC Temperature controller adjusted to +37°C and 
data was recorded with MC_Rack software (all from Multichannel 
systems, Reutlingen, Germany). Prior to measurements, MEA plates 
were sealed with semi-permeable membrane (standard MEAs) or 
PDMS discs (6-well MEAs) in laminar hood to keep the cultures 
sterile for repeated measurements as reported earlier (Potter and 
DeMarse, 2001).
Prior to MeHgCl exposure, the spontaneous baseline electrical 
activities of each MEA were measured (300 s/MEA) and only MEA 
cultures demonstrating spike train activity (at least 300 spikes detected 
at least from one channel per measurement period) were selected 
to experiment. One MEA from each MeHgCl concentration was 
recorded for 1 h to detect the acute response. Thereafter, each MEA 
was recorded at time points of 24, 48, and 72 h for 300 s for delayed 
response. After 72 h MEA cultures were washed with fresh medium 
and recovery responses were measured 72 h after washout.
Post-recording data was processed with MC_DataTool (MCS), 
MATLAB (MathWorks, Natick, MA, USA), Excel (Microsoft), and 
NeuroExplorer (NexTechnologies, Littleton, MA, USA). Peaks from 
MEA raw data were detected using threshold limit STD × (-5). From 
each MEA, total spikes/MEA, total spike number/active channel, 
and spiking rate/s were calculated. Spike number data was normal-
ized with respect to baseline activity to each MEA separately. For 
pharmacological response analysis, data was normalized against 
the mean of baseline activity period. Thereafter, each datapoint 
was smoothened with Gaussian smoother over ±25 timepoints and 
plotted into graph.
a well known neurotoxicant for both developing and adult central 
nervous system (Kaur et al., 2006) affecting microtubule disruption, 
oxidative stress, and neurotransmitter deregulation (Castoldi et al., 
2001) and causing focal damage in particular brain areas leading 
to manifestation of paresthesia, ataxia, constriction of visual field, 
and hearing loss in adult humans (Clarkson, 1993). During life 
span, humans are most sensitive to methyl mercury during the 
prenatal period which results in several severities range of mental 
retardation (Clarkson, 1993).
In this study we exposed spontaneously active human embryonic 
stem cell (hESC)-derived neuronal networks cultured in MEA’s 
to methyl mercury chloride (MeHgCl) at various concentrations 
and recorded both acute and delayed networks responses to this 
toxicant. We show that at subcytotoxic levels, the human neuronal 
networks’ response to this exposure can be detected with MEA but 
not with classical molecular biological analyses.
MaterIals and MetHods
reagents
Methyl mercury II chloride (MeHgCl), polyethyleneimine (PEI), 
mouse laminin, paraformaldehyde, γ-aminobutyric acid (GABA), 
and bicuculline methiobromide were purchased from Sigma-
Aldrich (St. Louis, MO, USA). 6-cyano-7-nitroquinoxaline-2,3-
dione (CNQX) and D(-)-2-amino-5-phosphonopentanoic acid 
(D-AP5) were from Ascent Scientific (Bristol, UK). B27 sup-
plement, N2 supplement, DMEM/F12 and Neurobasal media, 
Glutamax, and brain-derived neurotrophic factor (BDNF) were 
from Invitrogen (Carlsbad, CA, USA). Basic fibroblast growth 
factor (bFGF) was from R&D Systems (Minneapolis, MN, USA). 
Penicillin/streptomycin and phosphate buffered saline (dPBS) 
were from Lonza Group Ltd (Switzerland). 48-well and 96-well 
plates were from Nunc (ThermoFisher Scientific, Rochester, 
NY, USA).
Rabbit anti-microtubule associated protein 2 polyclonal antibody 
(MAP-2, 1:600), and monoclonal mouse anti-galactocerebroside 
(GalC, 1:400) were purchased from Chemicon. Monoclonal mouse 
anti-beta-tubulin isotype III (β-tubulin
III
, 1:1250) was purchased 
from Sigma and sheep anti-human glial fibrillary acidic protein 
antibody (GFAP, 1:800) was purchased from R&D systems.
cell culture
The hESCs grown as colonies were mechanically cut into aggre-
gates containing approximately 3000 cells and placed into sus-
pension culture in neural differentiation medium as recently 
reported (Lappalainen et al., 2010). Culture medium consisted of 
1:1 DMEM/F12 and Neurobasal media supplemented with 2 mM 
GlutaMax, 1 × B27, 1 × N2, and 25 U/ml penicillin/streptomycin. 
During neurosphere culture, constant supply of bFGF (20 ng/ml) 
was provided. The aggregates were differentiated for 8 weeks during 
which they formed round, constant neurospheres and expressed 
typical neural markers as described in the earlier studies (Hicks 
et al., 2009; Lappalainen et al., 2010). The medium was changed 
three times per week and growing spheres were manually cut into 
smaller spheres once a week.
After differentiation period cells were plated down onto MEA 
plates (Multi Channel Systems, Germany). Each standard MEA 
plate contains 59 titanium nitride measurement electrodes in 
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cytes, and GalC for oligodendrocytes. In the following day the cells 
were washed with 1% BSA in PBS and incubated with secondary 
antibodies (anti-mouse, anti-rabbit, or anti-sheep conjugated to 
Alexa Fluor-488 or 568, Molecular Probes, Invitrogen) diluted to 
the washing buffer for 1 h at RT. Finally, the cells were repeatedly 
washed with PBS and phosphate buffer, mounted with Vectashield 
with 4′6-diamidino-2-phenylindole (DAPI, Vector Laboratories, 
Peterborough, UK), and cover-slipped. For double-labeling, two 
primary antibodies and two secondary antibodies were applied 
simultaneously. When primary antibodies were omitted (negative 
control), no positive labeling was detected. Cells were imaged using 
an Olympus microscope (IX51, Olympus, Finland) equipped with 
a fluorescence unit and camera (DP30BW, Olympus, Finland).
cell prolIferatIon MeasureMents
BrdU
The proliferation rate of the neuronal cultures was measured 
72 h after MeHgCl washout using a colorimetric enzyme-linked 
immunosorbent assay (ELISA) for 5-bromo-2′-deoxyuridine 
(BrdU) (Roche, Basel, Switzerland), which is based on the BrdU 
incorporation into the DNA during strand synthesis. The manu-
facturer’s protocol was used with small modifications. Briefly, the 
networks were incubated with BrdU labeling reagent (100 μM) 
for 20 h at +37°C in 5% CO
2
. The cells were then collected and 
replated into 96-well plate wells (Nunc) at a density of 5000 
cells/well. Ten parallel samples/group were prepared. The well 
plates were centrifuged at 300 × g for 10 min at RT after which 
the medium was tapped off the wells. The cells were dried for 
15 min and fixed with FixDenat solution for 30 min at RT. The 
FixDenat solution was tapped off and anti-BrdU monoclonal 
antibody conjugated with peroxidase was added and incubated 
for 90 min at RT. The plates were then washed three times with 
dPBS and the substrate solution was added for 5 min. The reac-




and absorbance was measured at 
a 450-nm wavelength using a Viktor2 1420 Multilabel Counter 
(PerkinElmer-Wallac). The background absorbance (measured 
from negative controls) was subtracted from the measured sam-
ple absorbances.
Wst-1 analysis
Cell proliferation capacity was also measured with WST-1 reagent 
by evaluating succinate-tetrazolium reductase activity. Wst-1 Cell 
proliferation Assay (Takara Bio Inc., Shiga, Japan) was performed 
with ELISA from 12 parallel 96-wells/sample. Briefly, cells were 
once washed with PBS and ready-to-use solution of WST-1 was 
diluted into PBS and added to the cells. Cells were incubated for 
4 h in +37°C, 5% CO
2
 after which the measurement was performed 
with Viktor2 1420 Multilabel Counter at a 450-nm wavelength. The 
background absorbance (measured from negative controls) was 
subtracted from the measured sample absorbances.
results
HuMan eMbryonIc steM cell-derIved neural cells 
spontaneously forM electrIcally actIve networks
HESC-derived neuronal cell networks stay viable and active in 
MEA plates for several months and their activity can be meas-
ured repeatedly (Heikkilä et al., 2009). The spontaneous activity 
pHarMacologIc testIng
Pharmacological response to specific agonists and antagonists 
of AMPA/kainite, NMDA, and GABA receptors were tested with 
CNQX, D-AP5, GABA, and bicuculline in concentrations 30 μM, 
20 μM, 100 mM, and 20 μM, respectively. Response test were per-
formed immediately after the 72 h exposure period.
QuantItatIve rt-pcr analysIs
Samples for qRT-PCR analysis were collected from MEAs imme-
diately after 72 h MeHgCl exposure into lysis buffer and RNA 
was extracted using NucleoSpin® RNA XS kit according to the 
manufacturer’s instructions (Machery-Nagel GmbH & Co, Düren, 
Germany). Next, 200 ng of total RNA was reverse-transcribed into 
cDNA in reaction volume of 20 μl. The qRT-PCR was performed 
with standard protocol using ABI Prism 7300 instrument (Applied 
Biosystems, CA, USA) and TaqMan® Gene Expression assays (all 
from Applied Biosystems) for musashi (ID Hs01045894), neuro-
filament-68 (NF-68, ID Hs00196245), and GAPDH (ID 4331182) 
according to manufacturer’s instructions with TaqMan® Universal 
PCR master mix. All samples were performed as four technical rep-
licates. Briefly, the expression levels of musashi, NF-68, and GFAP 
were evaluated using GAPDH as an internal control. Ct values 
were determined for every reaction and the relative quantification 
was calculated using 2−∆∆Ct method (Livak and Schmittgen, 2001). 
Values of the control sample (not exposed to MeHgCl) were used 
as a calibrator.
tIMe-lapse IMagIng
For time-lapse imaging of the neuronal cultures during MeHgCl 
exposure, a subset of neurospheres were replated on mouse 
laminin (10 μg/ml, Sigma-Aldrich, St. Louis, MO, USA) coated 
48-well plates (8 parallel wells/MeHgCl concentration). The 
cells were allowed to grow as in MEA plates for 3 weeks until 
MeHgCl exposure. Thereafter, the well plate was transferred into 
a time-lapse imaging system (Cell-IQ®, Chip-man Technologies 
Ltd., Tampere, Finland) which allows for continuous monitoring 
of selected cells as described previously (Narkilahti et al., 2007). 
Briefly, sealed culture well plate was placed in a chamber (+36.5°C) 
with 5% CO
2
 gas supply. The cells of interest were selected for 
monitoring in 500 μm × 670 μm size areas or in grid areas 2 × 2 
(1500 × 2010 μm) using an all-in-focus imaging system (Tarvainen 
et al., 2002) and gained images were stored for later use in JPEG-
format. All areas of interest were imaged at 45-min interval for 
the total exposure time of 72 h. The cells were then fixed for 
immunocytochemical analysis.
IMMunocytocHeMIstry
The samples for immunocytochemical analyses were fixed with 
cold 4% paraformaldehyde for 20 min either after 72 h MeHgCl 
exposure or 72 h after washout. The fixed samples were blocked 
against non-specific antibody binding for 45 min in room tempera-
ture (RT) using 10% normal donkey serum (NDS), 0.1% Triton 
X-100, and 1% bovine serum albumin (BSA) in phosphate buffered 
saline (PBS). Next, the cells were washed with 1% NDS, 0.1% Triton 
X-100, and 1% BSA in PBS and incubated overnight at +4°C with 
primary antibodies diluted to the same buffer. The used antibodies 
were MAP-2 and ß-tubulin
III
 for neuronal cells, GFAP for astro-
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tradItIonal Molecular bIologIcal analyses dId not sHow 
MeHgcl-dependent effects on tHe neuronal networks
QRT-PCR analysis of the cells collected at the end of the MeHgCl 
exposure (72 h) did not show MeHgCl-related variation. Musashi 
was equally expressed by the cells treated with 0.5, 50, or 500 nM 
MeHgCl (Figure 4A). NF-68 was prominently expressed by the 
cells exposed to 0.5 or 50 nM MeHgCl (Figure 4A) but overall 
the expression of NF-68 in cells exposed to 500 nM MeHgCl was 
similar as in unexposed cells.
Immunocytochemical staining and analysis verified the simi-
larity of the neuronal networks regardless of the used MeHgCl 
concentration. MAP-2 and ß-tubulin
III
 positive neuronal cells were 
detected throughout the network (Figure 4B). Also, some GFAP 
positive astrocytes were detected in each group. In addition to neu-
ronal cells and astrocytes few cells among the networks stained 
positive for oligodendrocytic marker GalC (Figure 4B).
Time-lapse imaging was performed during MeHgCl exposure 
and it further verified that the unexposed cells or cells exposed to 
MeHgCl grew and proliferated in a similar fashion (Figure 5A).
Due to not detecting molecular biological differences between 
the unexposed or exposed cells we maintained a subset of cells for 
additional 72 h after removing the MeHgCl. These cells were ana-
lyzed for their proliferation capacity and protein expression using 
immunostaining. Proliferation of unexposed or MeHgCl exposed 
cells 72 h after MeHgCl washout was similar according to BrdU and 
WST-1 analyses (Figure 5B). Moreover, the network phenotype was 
similar as in the previous staining (data not shown).
dIscussIon
Here we have provided the first proof-of-principle that human ESC-
derived neuronal cells are suitable for neurotoxicological screen-
ing in MEA platform. The known neurotoxic substance, MeHgCl, 
caused alterations in functionality in spontaneously active human 
neuronal networks under subcytotoxic levels. This study underlines 
the need to develop more sensitive methods for neurotoxicology 
testing platforms and shows that MEA-based technologies are suit-
able for that purpose.
 develops in 3 weeks to a stage where the networks exhibit train-like 
 activity repeatedly from several channels. Figure 1A shows MEA 
plate with spontaneously active neuronal network. A raster plot 
showing prominent training activity of the network is represented 
in Figure 1B. For MeHgCl exposure only MEA plates with spon-
taneously active networks were selected.
MeHgcl does not Have acute effect on network actIvIty
Immediately after adding the cell culture medium containing 0, 
0.5, 50, or 500 nM MeHgCl one MEA/each group was measured 
for the first hour continuously to detect possible acute effects. No 
acute toxic effects were observed. The same natural fluctuation 
on spiking activity was detected in all MEAs and MeHgCl con-
centration-dependent alteration could not be observed during the 
measurement period (Figure 2).
MeHgcl exposure decreases network actIvIty In  
a delayed Manner
The used subtoxic doses of MeHgCl did not have acute effects but 
during longer exposure clear effects on spontaneous activity was 
detected. The activity of neuronal networks prominently decreased 
with each MeHgCl concentration when compared to 0 nM MeHgCl 
controls after 72 h exposure (Figures 3A,C).
MeHgcl exposed networks sHow alteratIon In tHeIr response 
to pHarMacologIcal substances
To evaluate the neuronal receptor actions in neuronal networks 
the pharmaceutical testing was performed. Control networks 
(0 nM MeHgCl) responded as expected as D-AP5, CNQX, and 
GABA inhibited but bicuculline excited the network activity. 
MeHgCl at concentrations 0.5 and 50 nM did not have effect 
on pharmaceutical response (data not shown). Alteration was 
detected on GABA and bicuculline response, however, with net-
works exposed to 500 nM MeHgCl as the signaling of the exposed 
networks was not completely silenced by GABA and the response 
to bicuculline was stronger when compared to the control net-
works. (Figure 3B).
Figure 1 | Spontaneously active neuronal networks in MeA. (A) HESC-derived neuronal cells form networks in vitro in MEA. (B) Formed networks show 
training activity within 3 weeks of culturing. Scale 200 μm. x-Axis time: 300 s, y-axis represents each channel.
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Figure 2 | Acute effect of MeHgCl exposure to neuronal network activity. The baseline activity (on the left) of one MEA in each group: (A) 0 nM MeHgCl, (B) 0.5 
nM MeHgCl, (C) 50 nM MeHgCl, (D) 500 nM MeHgCl exposure, and activity immediately after MeHgCl exposure (1 h, on the right). x-Axis time: baseline 300 s, 
acute response 600 s, y-axis represents each channel. Spikes are marked as rasters and heated colors represent increased activity rate.
Figure 3 | Delayed effect of MeHgCl exposure to neuronal network 
activity. (A) The activity of neuronal networks decreased toward 72 h of 
MeHgCl exposure in a concentration-dependent manner. The activity was 
measured from four parallel MEAs for 300 s at each timepoint. (B) 500 nM 
MeHgCl exposure altered the networks’ response to pharmacological 
substances. (C) Representative 3D plots of the activity rate/s (z-axis)/time 
(x-axis)/channel (y-axis) from one MEA/MeHgCl concentration at 72 h timepoint. 
Scales: activity rate/s 0–7 (bin = 1 s), time 300 s, channels 1–9. All data was 
gained as number of spikes/MEA which was normalized to the number of 
spikes at baseline.
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entiation (Carpenter et al., 2001; Reubinoff et al., 2001; Zhang et al., 
2001) opened up a new era for neurotoxicological field. Neuronal 
cells derived from hESCs most likely resemble the counterpart cells 
in the developing and adult human brain (Zeng et al., 2006). Thus, 
these cells could be used both for developmental and adult neuro-
toxicity testing as shown for 1-methyl-4- phenylpyridinium (MPP+) 
toxicity to hESC-derived dopaminergic neurons (Zeng et al., 2006). 
Here, we used hESC-derived neurosphere cultures which have been 
characterized for expression of neural markers previously (Heikkilä 
et al., 2009; Hicks et al., 2009; Sundberg et al., 2009; Lappalainen et al., 
2010). In addition, these cultures were shown to contain MAP-2 
or β-tubulin
III
 positive neurons and GFAP positive astrocytes after 
4 week culturing on MEA dishes.
The development of human-based cell models is highly needed 
for toxicological testing and drug screening studies. For neurotoxi-
cological studies, fetal human brain-derived cells have been used 
(Fritsche et al., 2005; Moors et al., 2009). These cells hold, however, 
limiting features such as origin and culturing time which makes their 
large scale use challenging. Other possible human-based cell sources 
considered for neurotoxicological studies are, e.g., SH-SY5Y human 
neuroblastoma cells (Biedler et al., 1973) or NT2 human teratocar-
cinoma cells (Bliss et al., 2006) which can be differentiated toward 
CNS cell types. These cells are, however, different from “normal” 
healthy cells by genetics and physiologics which raise questions on 
their behavior when exposed to toxic substances. The development of 
hESC culture methods (Thomson et al., 1998) and their neural differ-
Figure 4 | Molecular biological analyses of the cells after MeHgCl 
exposure. (A) The relative musashi and NF-68 mRNA expression of neuronal 
cells exposed to 0, 0.5, 50, or 500 nM MeHgCl did not show prominent 
variation. The data was normalized to the expression of house-keeping gene 
GAPDH, and values of unexposed cells were used as a calibrator set to 0 at 
y-axis. (B) The neuronal cell phenotypes appeared similar regardless of the 
MeHgCl concentration and stained positive for MAP-2, ß-tubulinIII, GFAP, and 
GalC (B). Scale 50 μm.
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Figure 5 | Time-lapse and proliferation analyses. (A) Time-lapse imaging 
verified the viability of the neuronal networks as no differences could be 
observed on morphologies during the 72 h of MeHgCl exposure. (B) Both 
BrdU and Wst-1 analyses asserted that all neuronal networks proliferated 
similarly 72 h after MeHgCl washout. Scale 100 μm.
Here, we focused to study the MeHgCl effects on reported 
 subcytotoxic levels (>1 μM in vitro) (van Vliet et al., 2008) to sponta-
neously active hESC-derived neuronal networks. The results showed 
that MeHgCl at 0.5–500 nM range caused concentration depended 
decrease in total spike activity during 72 h exposure compared to 
the control cultures. Previous, it has been reported that MeHgCl 
exposure caused decrease the evoked field potential amplitudes in 
rat primary telencephalon cultures in a concentration depended 
manner at 1–100 μM range whereas the effects on the spontane-
ous network activities were not reported (van Vliet et al., 2007). In 
addition to changes observed in functional level, we did not detected 
major changes caused by MeHgCl on cell morphology, prolifera-
tion, gene or protein expression on the studied concentrations. It 
has been shown that MeHgCl at a slightly higher concentration 
(750 nM) caused decrease in amount of differentiating β-tubulin
III
 
positive cells, and cell migration at 500 nM to 10 μM in human 
fetal brain cells which showed cytotoxicity to MeHgCl at 10 μM 
concentration (Moors et al., 2009). Although we did not study cell 
migration in more detail, the time-lapse imaging of treated cultures 
did not implicate that hESC-derived neuronal cell migration would 
be affected at studied MgHgCl concentrations (0.5–500 nM).
In this study we could show that MeHgCl at subcytotoxic levels 
clearly decreased the electrical functionality of hESC-derived net-
works. Harmful effects were not detected with traditional molecular 
biological methods. This clearly clarifies the advantage of MEA 
setup which is more sensitive to detect differences between groups 
treated with subcytotoxic concentrations. These results underline 
the need to study the subcytotoxic effects of different substances 
more carefully since they may reveal effects on functional prop-
erties which may or may not be acute, long-lasting, or even per-
manent. The MeHgCl exposed hESC-derived neuronal networks 
also showed distinct responses to pharmacologic substances. The 
network signaling decreased when treated with AMPA/kainate 
(CNQX) and NMDA (D-AP5) receptor antagonist and GABA 
agonist treatments as in control networks whereas the response for 
GABA
A
 receptor antagonist bicuculline was substantially stronger 
when compared to untreated networks. Thus it is possible, that 
72 h MeHgCl exposure had an effect on GABA receptor subunit 
expression on the hESC-derived neuronal cells. Interestingly, Bal-
Price and colleagues reported also changed responses to bicuculline 
in their study where primary rat cortical cultures were exposed to 
domoic acid (Hogberg et al., 2010). Unfortunately, due to small 
amounts of RNA gained from MEAs more detailed GABA recep-
tor subunit analysis with qRT-PCR could not be performed here. 
Thus, this will require further studies in the future.
Here we have showed that hESC-derived neuronal networks 
are indeed suitable for toxicological screening studies. The MEA 
platform is especially eligible for screening functional responses 
in spontaneously active neuronal networks that are missed with 
traditional molecular biology end-point analyses. We have shown 
that hESC-derived neural cells are capable of forming spontane-
ously active networks exhibiting signaling from sporadic single 
spiked to more mature synchronous bursting activity (Heikkilä 
et al., 2009). This setup is in routine use in our laboratory, thus it 
is highly applicable also for neurotoxicological studies. Regardless 
of the usability and enormous research possibilities MEA setup 
also holds its cons. The controllability of the networks is plating-
dependable thus batch to batch variation is expected. Also, standard 
glass MEA plates are not favored by hESC-derived neuronal cells 
and coatings are crucial for network forming capability. Also, the 
gained data is a large package to handle and analysis of it is chal-
lenging (Wagenaar et al., 2006; Illes et al., 2007; Heikkilä et al., 2009) 
and more standardized analysis methods should be developed. Also 
more structured networks gained by different surface patterning 
and guiding applications would enable more standardized func-
tional networks instead of the used spontaneously self organizing 
cultures that would increase the repeatability of the tests. In the 
future, the MEA setup offers an intriguing possibility to study neu-
ronal networks derived from human patients’ induced pluripotent 
stem cells (iPSCs) as we recently reported (Äänismaa et al., 2010). 
In deed, there are almost limitless possibilities to model genetic 
neurological deficiencies in vitro as well as perform, e.g., drug 
screening with these iPSC-derived neural cells. We conclude that 
MEA platform is highly suitable for neurotoxicological testing and 
would be a valuable addition to current analysis patterns.
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